Acasti Pharma Inc.
(ACST)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 |
| Cash & Equivalents | 23.00M | 27.88M | 30.34M | 50.94M | 14.24M | 16.87M | 6.37M | 2.23M | 1.05M | 607.09K | 1.17M | 1.60M | 329.43K | 392.75K |
| Short-Term Investments | - | 15.00K | 13.32M | 9.79M | - | 8.89M | - | 5.49M | 13.64M | 20.69M | 3.50M | 5.57M | 2.56M | - |
| Long-Term Investments | - | - | - | - | - | 20.22K | 20.13K | - | - | - | - | - | - | - |
| Other Long-Term Assets | -1 | - | - | -0.00 | 473.00K | 417.17K | 429.76K | 1.48M | - | 1.00 | - | - | - | - |
| Receivables | 722.00K | 802.00K | 548.00K | 530.00K | 546.00K | 1.19M | 587.73K | 294.30K | 682.99K | 1.03M | 816.60K | 1.09M | 456.16K | 467.52K |
| Inventory | - | - | - | - | 1.10M | 969.14K | 314.38K | -0.00 | 69.83K | 234.96K | 216.97K | 602.93K | 0.00 | - |
| Other Current Assets | 283.00K | 598.00K | 1.32M | 1.11M | 195.00K | 48.68K | 80.53K | 336.90K | 254.53K | 632.26K | 16.30K | 41.89K | 14.76K | - |
| Total Current Assets | 24.01M | 29.29M | 45.53M | 62.37M | 16.08M | 27.96M | 7.35M | 8.36M | 15.70M | 23.20M | 5.72M | 8.91M | 3.36M | 860.28K |
| Property-Plant & Equipment | 24.00K | 567.00K | 315.00K | 86.00K | 2.06M | 2.11M | 2.18M | 211.89K | 55.90K | 35.00K | 18.83K | 27.32K | 38.76K | 28.40K |
| Goodwill & Intangibles | 49.27M | 49.27M | 82.77M | - | 4.24M | 5.80M | 7.79M | 11.00M | 13.98M | 17.77M | 6.15M | 6.88M | - | - |
| Total Long-Term Assets | 49.29M | 49.83M | 83.09M | 86.00K | 6.77M | 8.34M | 10.43M | 12.69M | 14.04M | 17.81M | 6.16M | 6.91M | 38.76K | 28.40K |
| Total Assets | 73.30M | 79.12M | 128.62M | 62.46M | 22.85M | 36.30M | 17.78M | 21.04M | 29.74M | 41.01M | 11.89M | 15.82M | 3.40M | 888.68K |
| Account Payables | 1.01M | 1.24M | 1.68M | 115.00K | 1.71M | 3.04M | 2.65M | 276.88K | 197.03K | 287.31K | 317.57K | 552.43K | - | - |
| Deferred Revenue | - | -1.24M | - | - | - | 2.00 | - | - | - | - | - | - | - | - |
| Short-Term Debt | - | 75.00K | 104.00K | 86.00K | 76.00K | 1.36M | - | - | - | - | - | - | - | - |
| Other Current Liabilities | 677.00K | 3.34M | 1.48M | 1.38M | 5.61M | 9.26M | 2.54M | 565.05K | 1.10M | 764.96K | 2.07M | 714.40K | 967.19K | 4.53M |
| Total Current Liabilities | 1.68M | 3.41M | 3.26M | 1.58M | 7.39M | 13.67M | 5.19M | 841.93K | 1.30M | 1.05M | 2.39M | 1.27M | 967.19K | 4.53M |
| Long-Term Debt | - | 410.00K | 191.00K | - | 71.00K | - | 1.25M | - | - | - | - | - | - | - |
| Other Long-Term Liabilities | 4.36M | 9.93K | 10.00K | 5.22M | 2.39M | 12.18M | 4.98M | 115.40K | 1.88M | 10.05M | 317.57K | 552.43K | 4.27M | - |
| Total Long-Term Liabilities | 9.87M | 7.76M | 17.09M | 5.22M | 2.46M | 12.18M | 6.22M | 115.40K | 1.88M | 10.05M | 317.57K | 552.43K | 4.27M | - |
| Total Liabilities | 11.56M | 11.17M | 20.35M | 6.80M | 9.86M | 25.85M | 11.41M | 957.33K | 3.18M | 11.10M | 2.39M | 1.27M | 5.24M | 4.53M |
| Total Debt | - | 485.00K | 295.00K | 86.00K | 147.00K | 1.36M | 1.25M | - | - | - | - | - | - | - |
| Common Stock | 261.04M | 258.29M | 257.99M | 197.19M | 137.42M | 96.85M | 56.79M | 45.73M | 49.26M | 54.85M | 28.25M | - | 12.31M | 7.36M |
| Retained Earnings | -211.12M | -198.27M | -155.84M | -146.02M | -126.34M | -92.83M | -56.05M | -29.24M | -26.62M | -28.45M | -19.58M | -13.23M | -14.26M | -11.01M |
| Comprehensive Income | -6.04M | -6.04M | -6.04M | -6.33M | -7.89M | -888.26K | -527.33K | -81.85K | -41.65K | -43.55K | -42.12K | -35.44K | -25.04K | - |
| Shareholders Equity | 61.74M | 67.95M | 108.27M | 55.66M | 12.99M | 10.46M | 6.37M | 20.09M | 26.56M | 29.91M | 9.50M | 14.55M | -1.84M | -3.64M |
| Total Investments | - | 15.00K | 13.32M | 9.79M | - | 8.91M | 20.13K | 5.49M | 13.64M | 20.69M | 3.50M | 5.57M | 2.56M | - |